BioLife Solutions - 36 Year Stock Price History | BLFS
Historical daily share price chart and data for BioLife Solutions since 1989 adjusted for splits and dividends. The latest closing stock price for BioLife Solutions as of July 01, 2025 is 21.66.
- The all-time high BioLife Solutions stock closing price was 1373.75 on November 05, 1991.
- The BioLife Solutions 52-week high stock price is 29.55, which is 36.4% above the current share price.
- The BioLife Solutions 52-week low stock price is 18.70, which is 13.7% below the current share price.
- The average BioLife Solutions stock price for the last 52 weeks is 24.36.
| BioLife Solutions Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2025 | 24.3824 | 26.1800 | 28.4900 | 20.6400 | 21.6600 | -16.56% |
| 2024 | 21.4029 | 15.9800 | 27.4700 | 15.1400 | 25.9600 | 59.75% |
| 2023 | 17.9866 | 17.6700 | 26.0700 | 8.9900 | 16.2500 | -10.71% |
| 2022 | 20.7661 | 37.2900 | 37.2900 | 10.5400 | 18.2000 | -51.17% |
| 2021 | 41.5092 | 42.2300 | 60.5000 | 29.5100 | 37.2700 | -6.57% |
| 2020 | 20.8877 | 16.4000 | 45.7500 | 8.3600 | 39.8900 | 146.54% |
| 2019 | 17.1045 | 12.0000 | 21.2600 | 10.9000 | 16.1800 | 34.50% |
| 2018 | 11.5996 | 5.9600 | 25.4750 | 4.7330 | 12.0300 | 100.50% |
| 2017 | 3.5120 | 1.6200 | 6.9000 | 1.6200 | 6.0000 | 272.60% |
| 2016 | 1.7643 | 2.0500 | 2.3700 | 1.4500 | 1.6103 | -25.79% |
| 2015 | 2.0760 | 1.6400 | 2.7900 | 1.5000 | 2.1700 | 32.32% |
| 2014 | 3.4365 | 8.4000 | 9.0000 | 1.6400 | 1.6400 | -80.48% |
| 2013 | 7.2461 | 4.7600 | 19.6000 | 3.5000 | 8.4000 | 76.47% |
| 2012 | 2.2379 | 0.9800 | 6.3000 | 0.5642 | 4.7600 | 580.00% |
| 2011 | 1.0379 | 1.2600 | 1.5400 | 0.2800 | 0.7000 | -9.09% |
| 2010 | 1.0989 | 1.5400 | 1.7640 | 0.5600 | 0.7700 | -50.00% |
| 2009 | 1.5315 | 0.5600 | 2.9400 | 0.4340 | 1.5400 | 266.67% |
| 2008 | 0.7757 | 0.8400 | 1.2600 | 0.2800 | 0.4200 | -50.00% |
| 2007 | 1.4038 | 1.1200 | 2.3800 | 0.7000 | 0.8400 | -7.69% |
| 2006 | 1.1327 | 1.6100 | 1.6800 | 0.7700 | 0.9100 | -43.48% |
| 2005 | 1.7166 | 0.8400 | 3.5000 | 0.8400 | 1.6100 | 27.78% |
| 2004 | 1.9319 | 1.5400 | 3.3600 | 0.9800 | 1.2600 | -18.18% |
| 2003 | 1.7859 | 2.1000 | 3.0800 | 1.1200 | 1.5400 | -8.33% |
| 2002 | 2.1229 | 2.8000 | 4.0600 | 1.2600 | 1.6800 | -42.86% |
| 2001 | 4.3546 | 7.0000 | 9.6250 | 0.7700 | 2.9400 | -58.00% |
| 2000 | 19.8195 | 12.6000 | 51.1000 | 6.1250 | 7.0000 | -35.48% |
| 1999 | 24.5516 | 5.6000 | 64.3999 | 4.9000 | 10.8500 | 93.75% |
| 1998 | 13.0586 | 15.3125 | 32.8125 | 4.9000 | 5.6000 | -57.33% |
| 1997 | 27.9144 | 24.0625 | 50.3125 | 10.9375 | 13.1250 | -45.45% |
| 1996 | 126.4056 | 157.5000 | 231.8750 | 19.6875 | 24.0625 | -82.81% |
| 1995 | 202.6996 | 210.0000 | 258.1250 | 140.0000 | 140.0000 | -33.33% |
| 1994 | 220.4080 | 280.0000 | 328.1250 | 131.2500 | 210.0000 | -25.00% |
| 1993 | 405.6557 | 594.9990 | 594.9990 | 218.7500 | 280.0000 | -54.29% |
| 1992 | 662.6222 | 1023.7500 | 1067.5000 | 402.5000 | 612.4990 | -33.33% |
| 1991 | 349.3586 | 106.0940 | 1373.7500 | 102.8120 | 918.7490 | 775.00% |
| 1990 | 125.8518 | 144.3750 | 152.0310 | 105.0000 | 105.0000 | -28.36% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.023B | $0.082B |
| BioLife Solutions has pioneered the next generation of preservation solutions designed to maintain the viability and health of cellular matter and tissues during freezing, transportation and storage. Based on their proprietary bio-packaging technology and a patented understanding of the mechanism of cellular damage and death, these products enable the biotechnology and medical community to address a growing problem that exists today. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $236.635B | 28.45 |
| Boston Scientific (BSX) | United States | $158.907B | 39.78 |
| Stryker (SYK) | United States | $151.008B | 31.58 |
| EssilorLuxottica (ESLOY) | France | $127.124B | 0.00 |
| Medtronic (MDT) | Ireland | $111.799B | 15.85 |
| Lonza Group Ag (LZAGY) | Switzerland | $51.541B | 0.00 |
| Haleon (HLN) | United Kingdom | $46.605B | 26.59 |
| ResMed (RMD) | United States | $37.830B | 28.41 |
| GE HealthCare Technologies (GEHC) | United States | $33.916B | 16.10 |
| Agilent Technologies (A) | United States | $33.522B | 21.85 |
| Terumo (TRUMY) | Japan | $27.168B | 35.29 |
| Koninklijke Philips (PHG) | Netherlands | $23.091B | 16.20 |
| Insulet (PODD) | United States | $22.110B | 86.79 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.046B | 11.59 |
| Baxter (BAX) | United States | $15.539B | 11.60 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.415B | 0.00 |
| Demant (WILYY) | Denmark | $9.110B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.567B | 22.85 |
| Lantheus Holdings (LNTH) | United States | $5.664B | 14.29 |
| Prestige Consumer Healthcare (PBH) | United States | $3.946B | 17.63 |
| Perrigo (PRGO) | Ireland | $3.673B | 9.31 |
| Haemonetics (HAE) | United States | $3.584B | 16.33 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.312B | 27.52 |
| ICU Medical (ICUI) | United States | $3.252B | 23.98 |
| QuidelOrtho (QDEL) | United States | $1.949B | 13.40 |
| LeMaitre Vascular (LMAT) | United States | $1.876B | 41.94 |
| AtriCure (ATRC) | United States | $1.622B | 0.00 |
| Acuren (TIC) | United States | $1.341B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.273B | 12.92 |
| Green Thumb Industries (GTBIF) | United States | $1.167B | 26.24 |
| Neogen (NEOG) | United States | $1.037B | 13.28 |
| Phibro Animal Health (PAHC) | United States | $1.035B | 13.23 |
| InMode (INMD) | Israel | $0.913B | 9.20 |
| Kestra Medical Technologies (KMTS) | United States | $0.851B | 0.00 |
| Owens & Minor (OMI) | United States | $0.703B | 5.83 |
| CeriBell (CBLL) | United States | $0.677B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.614B | 0.00 |
| Evolus (EOLS) | United States | $0.594B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.559B | 0.00 |
| Valneva SE (VALN) | France | $0.482B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.454B | 0.00 |
| Surmodics (SRDX) | United States | $0.425B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.417B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.357B | 13.14 |
| Quanterix (QTRX) | United States | $0.332B | 0.00 |
| SNDL (SNDL) | Canada | $0.318B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.301B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.281B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.273B | 23.03 |
| Cerus (CERS) | United States | $0.270B | 0.00 |
| ZimVie (ZIMV) | United States | $0.260B | 11.84 |
| Sanara MedTech (SMTI) | United States | $0.252B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.252B | 0.00 |
| Brainsway (BWAY) | Israel | $0.248B | 65.75 |
| Aurora Cannabis (ACB) | Canada | $0.238B | 70.67 |
| OraSure Technologies (OSUR) | United States | $0.224B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.224B | 0.00 |
| Biote (BTMD) | United States | $0.220B | 6.18 |
| TriSalus Life Sciences (TLSI) | United States | $0.206B | 0.00 |
| High Tide (HITI) | Canada | $0.187B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.185B | 15.06 |
| Organigram Global (OGI) | Canada | $0.181B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.180B | 0.00 |
| Omeros (OMER) | United States | $0.176B | 0.00 |
| Exagen (XGN) | United States | $0.149B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.143B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.122B | 15.05 |
| Jin Medical (ZJYL) | China | $0.102B | 0.00 |
| Fonar (FONR) | United States | $0.093B | 11.97 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.092B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.085B | 0.00 |
| Veru (VERU) | United States | $0.085B | 0.00 |
| Apyx Medical (APYX) | United States | $0.085B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.080B | 0.00 |
| Zynex (ZYXI) | United States | $0.078B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.078B | 0.00 |
| MacroGenics (MGNX) | United States | $0.076B | 0.00 |
| InterCure (INCR) | Israel | $0.067B | 0.00 |
| Agape ATP (ATPC) | $0.066B | 0.00 | |
| Jushi Holdings (JUSHF) | United States | $0.064B | 0.00 |
| ImmuCell (ICCC) | United States | $0.063B | 0.00 |
| Nephros (NEPH) | United States | $0.043B | 58.43 |
| Modular Medical (MODD) | United States | $0.040B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.70 |
| Rockwell Medical (RMTI) | United States | $0.029B | 0.00 |
| Safety Shot (SHOT) | United States | $0.025B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.013B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Senestech (SNES) | United States | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |